New U.S. Clinical Studies Provide Further Validation for Aroa Biosurgery's Myriad™, as Products Also Approved for Use in India
Share: HIGHLIGHTS Further validation for Aroas Myriad™ from two clinical studies and peer-reviewed publications in Journal of Wound Care. One study shows high success rates, from use of Myriad™ in tissue reconstruction after surgical treatment of Hidradenitis Suppurativa, an inflammatory skin condition affecting around 1% of the adult population. A second study showed 100% success rates from use of Myriad™ when patients underwent surgical reconstruction of exposed vital structures such as...
United States New Zealand Brian Ward Tela Bio Hidradenitis Suppurativa American Society Of Plastic Surgeons
Source: benzinga.com